|Medicines Management Board Minutes October 2014 (177 KB)||02/12/2014||Download
| ||Vitamin D Guidleuines - children approved.
Brimonidine gel - symptomatic persistent facial erythema of rosacea - BLACK traffic light .
Opthalmology Macular pathways - approved.
Subcutaneous Tocilzumab - alternative to intravenous tocilizumab providing patient meets the prescribing criteria as set out in NICE technology appraisals for 1st, 2nd & 3rd line use to treat active rheumatoid arthritis and the agreed Lancashire Rheumatology Alliance flex for use as monotherapy - RED traffic light.
|Medicine Management Board Minutes 17th September 2014 (190 KB)||03/11/2014||Download
| ||ELHT Vitamin D Guidelines – Children - approved for use.
Rifaximin added to formulary for hepatic encephalopathy, for consultant gastroenterologist use only and a protocol. Traffic light: RED
Simeprevir to be included in formulary if NICE approve in January.
Pentoxifylline & Vitamin E for osteonecrosis of the jaw approved subject to satisfactory supply arrangements.
Osvaren included in formulary for renal use. Traffic Light: AMBER
Certolizumab - of adults with ankylosing spondylitis in line||
|Medicines Management Board Minutes 16th July 2014 (173 KB)||07/10/2014||Download
| ||Vesomni (solifenacin 6mg/tamsulosin 400mcg MR) - moderate to severe storage symptoms & voiding symptoms associated with benign prostatic hypoplasia - BLACk traffic light.
Lubiprostone - adults with chronic idiopathic constipation - BLACK traffic light.
Certolizumab -treatment of adults with active & progressive psoriatic arthritis in line with NICE TA199 - RED Traffic Light.
Armour Thyroid - unlicensed product - BLACK traffic light.
Canagliflozin - in combination therapy for treatment of typ||
|Medicine Management Board Minutes 21st May 2014 (179 KB)||31/07/2014||Download
| ||NOAC's position Statement - The position statement with a preferred option NOAC will not be pursued and all three will be available for prescribing, with traffic light remaining Amber.
NEW PRODUCT REQUESTS – CARBETOCIN and AZARGA EYE DROPS- deferred
|Medicines Management Board Minutes 18.06.2014 (183 KB)||31/07/2014||Download
| ||NEW PRODUCT REQUESTS – CARBETOCIN - formulary for use following elective caesarean section Traffic Light: RED
AZARGA EYE DROPS - second line when dorzolamide/timolol combination is not tolerated - Traffic Light: GREEN
|Medicines Management Board Minutes 16th April 2014 (226 KB)||12/06/2014||Download
| ||New Product Requests -Glycopyrronium for hyperhidrosis. Denosumab in prostate cancer. Hyoscine, melatonin Shared Care Protocol. NOAC's position Statement for East Lancashire Health Economy . New Product Request – Ostenil Plus. Erectile Dysfunction Guidelines. Blood Glucose Testing devices for Paediatrics. Unlicensed Request –Testosterone Gel, ELHT – JOINT CATHETER CARE FORMULARY. NEW PRODUCT REQUEST – BROMFENAC EYE DROPS. Denosumab Shared Care Guidelines. Strontium Ranelate. Indapamide, NICE REC||
|Medicines Management Board Minutes 19th March 2014 (183 KB)||06/05/2014||Download
| ||Xiapex Policy and Form updated. ELHT bowel prepartion PIL finalised.
ELHT Fosfomycin for UTI protocol - joint letter to be sent to GPs.
New product Request - Ostenil Plus - rejected.
ED Guidelines completed. Unlicensed Request - Pilocarpine for dry mouth on specialist palliative care initiation - AMBER traffic light.
ELHT medicines policy updated and acknowledged by ELMMB.
Dapoxetine - was BLACK traffic light now Grey Under Review.
Fluarix Tetra - Grey under review awaiting guidance from N||
|Medicines Management Board Minutes February 2014 (196 KB)||25/03/2014||Download
| ||New product request Ostenil Plus - not approved for osteoarthritis. MSK service to be informed that hyaluronon injections should not be used. Traffic light: BLACK
Golimumab for moderate to severe ulcerative colitis - Traffic Light: BLACK
Omega 3 Fatty Acids Post MI position Statement - updated position statement accepted for use in ELHE.
MEDICINES RECONCILIATION POLICY updated and accepted by ELMMB. To be incorporated into current Health Economy Transfer of Care Policy.
ELHT updated Breastf||
|Medicines Management Board Minutes January 2014 (189 KB)||25/03/2014||Download
| ||Xiapex Policy and form updated. ELHT bowel preparation PIL's updated
New product request - Pivmecillinam - approved for use in UTI on microbiology advice - AMBER traffic light.
Lidocaine & Fluorescein unit dose eye drops - added to fornulary -RED traffic light.
Proxymetacaine unit dose eye drops - added to formulary - RED traffic light.
Strontium ranelate sachets - removed from formulary following recent EMA recommendations.
ELHT prescribing accuracy audit acknowledged by ELMMB.
|Medicines Management Board Minutes ELHE December 2013 (277 KB)||29/01/2014||Download
| ||New Product Requests: Rotigotine - not recommended for restless leg syndrome. To be considered as part of a review guideline - BLACK Traffic Light.
Flutiform - not recommended for asthma. To be considered as part of asthma guideline - BLACk Traffic Light.
LMMG Recommendations - Taurine inf CF Liver Disease - BLACK Traffic Light. Guidelines for Good Prescribing in Primnary care - updated ELHE guideline for use in Lancashire - accepted for ELHE as written.
Prescribing Guidleines for NOACs in A||
|Medicines Management Board Minutes 20th November 2013 (193 KB)||06/01/2014||Download
| ||New Product Requests -Epiduo Gel® - for 1st line treatment of acne vulgaris - Green traffic light. Melatonin for critical care - mangement of sleep impairment in critcalkly unwell patients - Red Traffic Light.
ingenol mebuate (Picato®)- GREEN traffic light, Fluorouracil+salicylic acid (Actikerall®) and imiquimod 3.75% (Zyclara®) - BLACK traffic light.
Oxcarbazepine (Trileptal®) for use as monotherapy or adjunctive therapy in partial epilepsy only when carbamazepine, lamot||
|Medicines Management Board Minutes September 2013 (195 KB)||03/12/2013||Download